Search

everythinglearnresearchcommunity

for

Search:↓

The case shows skin changes can indicate deeper health issues like insulin resistance, which are challenging to manage.

Most women with excessive hair growth have a hormonal cause.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Finasteride may negatively affect male fertility.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Follicle Stimulating Hormone is important for fertility.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Acne is strongly linked to high BMI, hair loss, menstrual issues, family history, and eating too many sweets and fatty foods, but not to excessive hair growth.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

PCOS is often linked with menstrual issues, hormonal imbalances, and a higher risk of heart disease and diabetes.